Warning: fopen(/home/virtual/pediatrics/journal/upload/ip_log/ip_log_2024-12.txt) [function.fopen]: failed to open stream: Permission denied in /home/virtual/pediatrics/journal/ip_info/view_data.php on line 93

Warning: fwrite(): supplied argument is not a valid stream resource in /home/virtual/pediatrics/journal/ip_info/view_data.php on line 94
Efficacy of leuprolide acetate versus triptorelin pamoate administered every 3 months for treatment of central precocious puberty

Clin Exp Pediatr > Accepted Articles
DOI: https://doi.org/10.3345/cep.2024.00822    [Accepted]
Published online November 6, 2024.
Efficacy of leuprolide acetate versus triptorelin pamoate administered every 3 months for treatment of central precocious puberty
Thanaporn Thaneetrakool1, Suphab Aroonparkmongkol1, Nattakarn Numsriskulrat1,2, Vichit Supornsilchai1, Suttipong Wacharasindhu1, Khomsak Srilanchakon1 
1Division of Pediatric Endocrinology, Department of Pediatrics, Faculty of medicine, Chulalongkorn University, Bangkok, Thailand
2Division of Academic Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
Correspondence: 
Khomsak Srilanchakon, Email: khomsak_s@hotmail.com
Received: 17 May 2024   • Revised: 14 July 2024   • Accepted: 14 July 2024
Abstract
Background
Central precocious puberty (CPP) is typically treated with gonadotropin-releasing hormone (GnRH) agonists. Although numerous GnRH agonist variants are available, limited research has compared the efficacy of leuprolide acetate and triptorelin pamoate administered at 3-month intervals.
Purpose
This study aimed to assess the efficacy of CPP treatment with triptorelin pamoate and leuprolide acetate administered at 3-month intervals.
Methods
This retrospective cohort study included 116 girls with CPP: 71 treated with leuprolide acetate every 3 months and 45 treated with triptorelin pamoate every 3 months. Anthropometric measurements were compared before and after therapy. At 6 months after the therapy, luteinizing hormone (LH) suppression was evaluated.
Results
When administered every 3 months, leuprolide acetate and triptorelin pamoate significantly suppressed LH. The predicted adult height (PAH) and degree of bone age advancement at the end of treatment were comparable.
Conclusion
Treatment with leuprolide acetate and triptorelin pamoate every 3 months did not have significantly different effects on LH suppression or PAH.
Key Words: Efficacy, Leuprolide acetate, Triptorelin pamoate, 3-Monthly GnRH agonist, Central precocious puberty


METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 632 View
  • 35 Download